Stada has received another offer for the acquisition



The German company Stada, specializing in the production of generic drugs, announced the receipt of a third acquisition proposals, the name of the prospective buyer is not informed.

According to the company, the amount of the offer is 58 euros ($61,89) per share, which is above proposed by the company Cinven Partners 56 euros per share.

It should be noted that a third potential buyer is private equity firm Advent International, however, the amount of its offer is unknown.



Stada has received another offer for the acquisition 17.02.2017

Share with traders

Share to Google Plus
Share to LiveJournal
Share to MyWorld
Share to Odnoklassniki